Literature DB >> 1704516

Linking: a mechanism of intermittent preexcitation in the Wolff-Parkinson-White syndrome.

H R Middlekauff1, W G Stevenson, T S Klitzner.   

Abstract

Intermittent preexcitation in the Wolff-Parkinson-White syndrome has been equated with a long accessory pathway refractory period and long R-R interval between preexcited beats in atrial fibrillation and therefore a low risk for sudden death. A case of Wolff-Parkinson-White syndrome in which preexcitation became intermittent following procainamide infusion, with only moderate prolongation of the accessory pathway refractory period but marked prolongation of the shortest preexcited R-R interval in atrial fibrillation, is described. Programmed ventricular and atrial stimulation demonstrated that intermittent preexcitation was caused by concealed conduction producing a linking phenomenon, facilitated by the antiarrhythmic drug. Linking due to concealed retrograde penetration of a propagated impulse into the accessory pathway may contribute to the disparity between accessory pathway refractory period and shortest preexcited R-R interval in atrial fibrillation in some patients and may be a confounding factor in the interpretation of noninvasive tests of accessory pathway conduction.

Entities:  

Mesh:

Year:  1990        PMID: 1704516     DOI: 10.1111/j.1540-8159.1990.tb06865.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  2 in total

1.  Intermittent preexcitation indicates "a low-risk" accessory pathway: Time for a paradigm shift?

Authors:  Marek Jastrzębski; Piotr Kukla; Maciej Pitak; Andrzej Rudziński; Adrian Baranchuk; Danuta Czarnecka
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05-12       Impact factor: 1.468

2.  Transient appearance of antegrade conduction via an AV accessory pathway caused by atrial fibrillation in a patient with intermittent Wolff-Parkinson-White syndrome.

Authors:  S Niwano; Y Kitano; M Moriguchi; T Izumi
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.